Tag | Content |
---|
EnhancerAtlas ID | HS196-13250 |
Organism | Homo sapiens |
Tissue/cell | ZR75-1 |
Coordinate | chr19:36192900-36193820 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
NFYA | MA0060.3 | chr19:36193359-36193370 | GGCCAATCAGA | + | 6.02 | NFYB | MA0502.1 | chr19:36193471-36193486 | GAGCCAGCCAATCAG | + | 6.04 | TFAP2A | MA0003.3 | chr19:36193108-36193119 | CGCCTCAGGCT | + | 6.14 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_19716 | chr19:36192977-36193968 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_59463 | chr19:36184851-36210443 | Ly3 | SE_61403 | chr19:36184821-36210454 | HBL1 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH19I035701 | chr19 | 36192703 | 36194302 |
|
Enhancer Sequence | GTTACAGGCA TCCCCCACCA CGCCCGGCTA ATTTTTGTAT TTTTAGTAGA GACGGGGTTT 60 CACCATATTG GTCAGGCTGG TCTCGAACTC CTGACCTCAG GTGATCTGCC CGCCTTAGCC 120 TCCCAAAGTG CTGGGATTAC AGGCGTGAGC CACCACGTCC GGCCCCTTCC CCCATTTTAG 180 CGGTTTCGCT CCCTATCGGG GCCAGGGACG CCTCAGGCTG TCTCGGTCAG GACCTACAGC 240 TCCGGTTGTT GTCCCAGGCT CTTCCGCGAG GTGCTCTCCT GTCTCCTGAC CACCCCCATT 300 CCTCCCCACT CCAGCTCCTC AGCGAGCGGC TGCGAAGGAC GCGCACAACA ACACTCCGCG 360 CAGCGGGAAG GTACCGAACT CGCATCGCAG CCTGAAACTG CTCAACTAAG CTCCCGCCCC 420 GCTGCTCTCT GGTCAATCTA AAGCGAAGAC GAGCCTTAGG GCCAATCAGA AGCGACAGCG 480 GTGGAGTCAT GCCCGCCTGC TTGAGGCGCC CTGGCGTCTC ATTGGCTATG CTTGAGAACG 540 AATCCCAGGC TAAGCCACTT AGAAAGGAGC GGAGCCAGCC AATCAGCGGT GCAACCGCCG 600 CGGGGGCCGG GCCAGAAGCC CCGCAGACAA GCACCTCGGG AGACTGGCGA GGGGCGAGCT 660 CGCAGCTTGT TAGCCCCGAA GCCCTGCCCA GGGGGAAACC CTGCTGGAGG GAGTCTAACC 720 CCCGGGCCAG TTAATGTTGG GGCAGCGCAA TCGGCCGTTC CCTCTGCGGT ATGGTTGGAG 780 GTGGGAGTGC TGACACGTCC GCGCGCAGTT ACTCCTGGCT GAGCATACAG TCGAGGTGGC 840 AGTGGGAATT GGAAGTGCAA GTGTCACGCT GCCAATCACG GGGCAAGGCA CTGCCCCCCT 900 CTTGTGTCTT TCCTGTCCCT 920
|